These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9641673)

  • 1. HIV. Envelope's letters boxed into shape.
    Moore JP; Binley J
    Nature; 1998 Jun; 393(6686):630-1. PubMed ID: 9641673
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational properties of HIV-1 gp120/V3 immunogenic domains.
    Galanakis PA; Spyroulias GA; Rizos A; Samolis P; Krambovitis E
    Curr Med Chem; 2005; 12(13):1551-68. PubMed ID: 15974987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of V3 loop flexibility and net charge in the context of co-receptor recognition. A molecular dynamics study on HIV gp120.
    Chandramouli B; Chillemi G; Abbate I; Capobianchi MR; Rozera G; Desideri A
    J Biomol Struct Dyn; 2012; 29(5):879-91. PubMed ID: 22292949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
    Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
    Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing HIV's T cell passkey.
    Balter M
    Science; 1998 Jun; 280(5371):1833-4. PubMed ID: 9669932
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120.
    Chandramouli B; Chillemi G; Giombini E; Capobianchi MR; Rozera G; Desideri A
    J Biomol Struct Dyn; 2013 Apr; 31(4):403-13. PubMed ID: 22876913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for the disulfide-bonded region of human immunodeficiency virus type 1 gp41 in receptor-triggered activation of membrane fusion function.
    Bellamy-McIntyre AK; Bär S; Ludlow L; Drummer HE; Poumbourios P
    Biochem Biophys Res Commun; 2010 Apr; 394(4):904-8. PubMed ID: 20230797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV: conformational camouflage.
    Jardetzky T
    Nature; 2002 Dec; 420(6916):623-4. PubMed ID: 12478278
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamic domains and geometrical properties of HIV-1 gp120 during conformational changes induced by CD4 binding.
    Liu SQ; Liu SX; Fu YX
    J Mol Model; 2007 Mar; 13(3):411-24. PubMed ID: 17131136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
    Arthos J; Cicala C; Selig SM; White AA; Ravindranath HM; Van Ryk D; Steenbeke TD; Machado E; Khazanie P; Hanback MS; Hanback DB; Rabin RL; Fauci AS
    Virology; 2002 Jan; 292(1):98-106. PubMed ID: 11878912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
    Liu S; Fan S; Sun Z
    J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polyanionic inhibitors of HIV adsorption].
    Baranova EO; Shastina NS; Shvets VI
    Bioorg Khim; 2011; 37(5):592-608. PubMed ID: 22332354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restraining the conformation of HIV-1 gp120 by removing a flexible loop.
    Rits-Volloch S; Frey G; Harrison SC; Chen B
    EMBO J; 2006 Oct; 25(20):5026-35. PubMed ID: 17006538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.
    Xiao X; Norwood D; Feng YR; Moriuchi M; Jones-Trower A; Stantchev TS; Moriuchi H; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):139-46. PubMed ID: 10816382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
    Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
    Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coreceptor usage and biological phenotypes of HIV-1 isolates.
    Cilliers T; Morris L
    Clin Chem Lab Med; 2002 Sep; 40(9):911-7. PubMed ID: 12435108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in HIV treatment include HIV envelope tropism and inhibition.
    Besch CL
    HIV Clin; 2008; 20(1):1-3. PubMed ID: 18574885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.